Clinical trial Recruiting at 1 site Observational Ages 18 to 60

Modulating brain alpha rhythms to improve attentional control

Official title: EEG Alpha Rhythm Modulation Using Sham Neurofeedback During Attentional Control in a Virtual Reality Environment

Run by National Council of Scientific and Technical Research, Argentina · NCT06748976 · Data updated 2026-11-12

This research will try an open-loop sham neurofeedback setup in adults with rumination or chronic pain (including fibromyalgia) to see if positive or negative feedback in virtual reality changes EEG alpha rhythms linked to attention.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexAll
Enrollment35 (estimated)
SponsorNational Council of Scientific and Technical Research, Argentina
Government
Locations1 site (Oro Verde, Entre Ríos Province)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedNovember 2025
Study endsNovember 2025
Registry record updatedSeptember 25, 2025
Trial IDNCT06748976 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 with rumination or chronic pain (including fibromyalgia), normal or corrected vision, ability to use a VR headset, and no photosensitive epilepsy, significant hearing loss, migraines, current psychiatric disorder, substance abuse, or pregnancy are ideal candidates.

Probably not a fit

People with current psychiatric disorders, photosensitive epilepsy, significant hearing loss, migraines, substance abuse history, pregnancy, or who cannot tolerate virtual reality would likely be excluded or may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a within-subject design participants experience three conditions—positive sham neurofeedback, negative sham neurofeedback, and no-feedback control—while immersed in a virtual reality environment. EEG is recorded throughout to measure relative alpha power as a marker of attentional resource allocation. Researchers will compare alpha power across conditions to see if open-loop feedback produces decreases in alpha associated with increased attention. Adults aged 18–60 are screened for exclusions such as photosensitive epilepsy, migraines, significant hearing loss, current psychiatric illness, substance abuse, pregnancy, or intolerance to VR.

Why it matters

Potential benefit: If successful, this approach could provide a simple, low-cost way to nudge attention-related brain rhythms and potentially reduce rumination or improve coping with chronic pain.

How similar studies have gone: Closed-loop alpha neurofeedback has shown some success in altering attention-related EEG rhythms, but open-loop sham neurofeedback for this purpose is largely novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged between 18 and 60 years.
* Normal or corrected vision.
* Ability to provide written informed consent.

Exclusion Criteria:

* Diagnosed with photosensitive epilepsy.
* Significant hearing loss or diagnosed hearing impairment.
* Current psychiatric illness or disorder.
* History of migraines or chronic headaches.
* History of substance or alcohol abuse.
* Currently pregnant.
* Discomfort with using a virtual reality headset, assessed during a pilot session.

Where it's running

  • Facultad de Ingeniería, Universidad Nacional de Entre Ríos
    Oro Verde, Entre Ríos Province, Argentina
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Emotional Allodynia in Fibromyalgia: AEQ Validation

    This study tests whether the Emotional Allodynia Questionnaire (AEQ) reliably identifies emotional overreaction to social cues in adults with fibromyalgia compared with other chronic pain patients.

    Recruiting University of Bari · Bari and 4 other locations · NCT07677631

  • Multisite rTMS for fibromyalgia with depressive symptoms

    This study tests whether stimulating both the motor and prefrontal brain areas with repetitive transcranial magnetic stimulation can reduce pain in fibromyalgia patients who also have depressive symptoms.

    Recruiting Hospital Ambroise Paré Paris · Boulogne-Billancourt, Île-de-France Region · NCT07642882

  • Understanding subtypes of chronic musculoskeletal pain in youth

    This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.

    Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07602595

  • Shiatsu therapy for long-lasting non-inflammatory pain in children and teens

    This study will try weekly 30-minute Shiatsu sessions alongside regular care to see if they improve quality of life for children and adolescents (ages 10–18) with non-inflammatory chronic pain.

    Recruiting Tel Aviv University · Tel Aviv, Tel Aviv and 1 other locations · NCT06929598

  • Comparing two physiotherapy approaches for fibromyalgia

    This study tests whether a new physiotherapy program that includes education and personalized exercises can help people with fibromyalgia feel less pain and function better compared to standard physiotherapy.

    Recruiting Al Hayah University In Cairo · Cairo · NCT06913868

  • Chromatic Retinal Stimulation to Help With Chronic Pain

    This study tests whether different color light delivered to the retina can reduce pain and pain sensitivity in adults with fibromyalgia or chronic low back pain.

    Recruiting University of North Carolina, Chapel Hill · Chapel Hill, North Carolina · NCT05956067

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.